Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Common Stock | 269K | $2.42M | $9.01 | Nov 25, 2024 | Direct |
OCULAR THERAPEUTIX, INC | Chief Scientific Officer | Stock Option (Right to Buy) | 200K | Oct 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUL | OCULAR THERAPEUTIX, INC | Nov 25, 2024 | 1 | -$26.6K | 4 | Nov 27, 2024 | Chief Scientific Officer |
OCUL | OCULAR THERAPEUTIX, INC | Oct 2, 2024 | 2 | $0 | 4 | Oct 4, 2024 | Chief Scientific Officer |
OCUL | OCULAR THERAPEUTIX, INC | Oct 2, 2024 | 0 | $0 | 3 | Oct 4, 2024 | Chief Scientific Officer |
OCUL | OCULAR THERAPEUTIX, INC | Aug 2, 2023 | 1 | $0 | 4 | Aug 18, 2023 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Oct 17, 2022 | 1 | $0 | 4 | Oct 18, 2022 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
OCUL | OCULAR THERAPEUTIX, INC | May 12, 2022 | 1 | $45.8K | 4 | May 16, 2022 | Director |
OCUL | OCULAR THERAPEUTIX, INC | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |